Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
8.54
+0.39 (4.79%)
Feb 3, 2026, 1:01 PM EST - Market open
Relay Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts that cover Relay Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $15.75, which forecasts a 84.43% increase in the stock price over the next year. The lowest target is $10 and the highest is $23.
Price Target: $15.75 (+84.43%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Relay Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 6 | 6 | 6 |
| Buy | 4 | 4 | 4 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 13 | 9 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $14 | Hold → Buy | Upgrades | $14 | +63.93% | Jan 26, 2026 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $6 → $13 | Hold → Buy | Upgrades | $6 → $13 | +52.22% | Dec 12, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $4 → $6 | Hold | Maintains | $4 → $6 | -29.74% | Nov 7, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +75.64% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $14 | Strong Buy | Maintains | $16 → $14 | +63.93% | Aug 26, 2025 |
Financial Forecast
Revenue This Year
12.00M
from 10.01M
Increased by 19.96%
Revenue Next Year
8.08M
from 12.00M
Decreased by -32.66%
EPS This Year
-1.77
from -2.36
EPS Next Year
-1.69
from -1.77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 40.3M | 42.2M | ||||
| Avg | 12.0M | 8.1M | ||||
| Low | 7.8M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 302.9% | 251.6% | ||||
| Avg | 20.0% | -32.7% | ||||
| Low | -21.7% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.58 | -1.41 | ||||
| Avg | -1.77 | -1.69 | ||||
| Low | -2.04 | -2.24 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.